AnalystsDavid DaiDavid Dai's Stock Forecasts
AnalystsDavid Dai
Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4853 out of 5069 analysts
Average Return
-13.94%
Win Rate
29%7 out of 24
Risk vs Reward
Poor
Good
David Dai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Jdcom IncJD | +122.61% | $38.35 | $85.37 | 2020-03-17 - 2021-03-17 | Buy |
Merus NvMRUS | +80.02% | $52.30 | $94.15 | 2024-10-24 - 2025-09-30 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +55.27% | $9.21 | $14.30 | 2025-07-15 - 2025-10-17 | Strong Buy |
Kura Oncology IncKURA | +27.79% | $7.70 | $9.84 | 2025-03-06 - 2025-10-17 | Strong Buy |
Nuvalent IncNUVL | +20.14% | $77.01 | $92.52 | 2025-03-14 - 2025-10-17 | Strong Buy |
David Dai Analyst Color
Get additional color on David Dai's coverage of popular stocks
David Dai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Merus NvMRUS | 2 | Hold | $97.00 | +2.22% | Downgrades | 19 days ago |
Telix Pharmaceuticals LtdTLX | 1 | Strong Buy | $20.00 | +85.19% | Maintains | a month ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $35.00 | +144.76% | Maintains | 3 months ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $26.00 | +164.23% | Maintains | 3 months ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $30.00 | +42.93% | Initiates Coverage On | 4 months ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $129.00 | -0.36% | Maintains | 4 months ago |
Iovance Biotherapeutics IncIOVA | 2 | Hold | $2.00 | -8.26% | Downgrades | 5 months ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $24.00 | +205.54% | Maintains | 5 months ago |
Nuvalent IncNUVL | 2 | Strong Buy | $100.00 | +8.08% | Upgrades | 7 months ago |
Kura Oncology IncKURA | 2 | Strong Buy | $14.00 | +42.28% | Maintains | 7 months ago |
Immunocore Holdings PLCIMCR | 1 | Strong Sell | $24.00 | -28.49% | Initiates Coverage On | a year ago |
Perspective Therapeutics IncCATX | 1 | Strong Buy | $20.00 | +345.43% | Initiates Coverage On | a year ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $69.00 | +157.85% | Initiates Coverage On | a year ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | +70.88% | Initiates Coverage On | a year ago |
Cg Oncology IncCGON | 1 | Strong Buy | $60.00 | +44.72% | Initiates Coverage On | a year ago |
Adicet Bio IncACET | 1 | Buy | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Inhibrx IncINBX1 | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Macrogenics IncMGNX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Nkarta IncNKTX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Jdcom IncJD | 1 | Buy | $52.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.